Integrating and optimizing tonabersat in standard glioblastoma therapy: A preclinical study
In conclusion, this preclinical investigation highlights tonabersat’s potenti al as an effective adjuvant treatment for GB, and its established safety profile from clinical trials in migraine treatment presents a promising foundation for further exploration.
Source: PLoS One - Category: Biomedical Science Authors: Velislava Zoteva Source Type: research
More News: Biomedical Science | Brain | Brain Cancers | Brain Tumor | Chemotherapy | Clinical Trials | Glioma | Headache | Migraine | Neurology | Study | Temodar